Get a Free 5ml Mini Now Free 5ml Mini With Every Order of The Mantle

NICOTIANA BENTHAMIANA SH-POLIPEDTIDE-45.

Insufficient Data / SKIN CONDITIONING

NICOTIANA BENTHAMIANA SH-POLIPEDTIDE-45 is a bio-engineered polypeptide designed to function as a skin conditioning agent. It is understood to support the skin's inherent protein structures, aiming to enhance firmness, elasticity, and hydration for a revitalized complexion.

Skin Conditioning Anti-Aging Firming Elasticity Enhancer Hydration Support

Science

This ingredient operates as a skin conditioning agent, leveraging the fundamental role of peptides as precursors for crucial dermal proteins, including collagen, elastin, and keratin. It is theorized to promote the endogenous synthesis of collagen, thereby contributing to the skin's structural resilience and improved elasticity. Additionally, its action is believed to assist in maintaining optimal epidermal moisture levels, which can visibly reduce the appearance of fine lines and wrinkles.


Research

Low confidence
Effective range N/A
Optimal

N/A


Transparency

Not commonly dusted

There is no specific clinical data or widespread marketing claims available for NICOTIANA BENTHAMIANA SH-POLIPEDTIDE-45 to indicate a pattern of 'dusting' or unsubstantiated hype.


The Formula

Solubility
Unknown
Optimal pH N/A
0 7 14

Safety

CIR Status
Not reviewed
Sensitization risk Unknown

No dedicated safety assessments by the Cosmetic Ingredient Review (CIR), Scientific Committee on Consumer Safety (SCCS), or U.S. Food and Drug Administration (FDA) have been identified for NICOTIANA BENTHAMIANA SH-POLIPEDTIDE-45. In cases of limited data or absence from FDA's Voluntary Cosmetics Reporting Program, ingredients may be categorized by CIR as 'Insufficient Data' or 'No Reported Uses'. Overall product safety is generally addressed by broader cosmetic regulatory frameworks, such as those within the EU.


Your Skin

No Normal
No Dry
No Oily
No Sensitive
Irritancy Unknown
Comedogenicity Unknown

Our Assessment

Insufficient Data

While conceptually promising as a peptide, the current absence of specific clinical studies and comprehensive safety assessments for NICOTIANA BENTHAMIANA SH-POLIPEDTIDE-45 warrants an 'insufficient-data' classification for precise formulation guidance.


Related

Finding similar ingredients…